Clinical value of anticoagulant combined with atorvastatin calcium in the treatment of cerebral infarctionAuthor(s): Ying Tang & Yuan Xu
Objective: To analyze the clinical effect of anticoagulant combined with atorvastatin calcium in the treatment of cerebral infarction.
Methods: 84 patients with cerebral infarction were randomly divided into the observation group and the control group. The control group was treated with aspirin and low molecular weight heparin sodium. The observation group was treated with atorvastatin calcium on the basis of the control group, and the NHISS (National Institute Healthstroke scale) score (nerve function defect score) and serum CRP (Cost Reduction Program) (C inverse) were compared before and after the treatment in the two groups. The concentration change and total efficiency of the protein).
Results: Before treatment, there was no significant difference between the two groups of patients’ NHISS score and serum CRP concentration (P>0.05). After treatment, the NHISS score and serum CRP concentration in the observation group were significantly different from those in the control group (P<0.05), and the total effective rate of the observation group and the control group was 88.10% and 61.90% separately. The difference is significant (P<0.05).
Conclusion: Aspirin, low molecular heparin sodium combined with atorvastatin calcium has significant clinical effect in the treatment of cerebral infarction.